1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
SLUG transcription factor : A pro-survival and prognostic factor in gastrointestinal stromal tumour
Pulkka, Olli Pekka ; Nilsson, Bengt ; Sarlomo-Rikala, Maarit ; Reichardt, Peter ; Eriksson, Mikael LU
; Hall, Kirsten Sundby
; Wardelmann, Eva
; Vehtari, Aki
; Joensuu, Heikki
and Sihto, Harri
(2017)
In British Journal of Cancer
116(9).
p.1195-1202
- Contribution to journal › Article
-
Mark
Effect of KIT and PDGFRA mutations on survival in patients with gastrointestinal stromal tumors treated with adjuvant imatinib : An exploratory analysis of a randomized clinical trial
Joensuu, Heikki ; Wardelmann, Eva ; Sihto, Harri ; Eriksson, Mikael LU
; Sundby Hall, Kirsten
; Reichardt, Annette
; Hartmann, Jörg T
; Pink, Daniel
; Cameron, Silke
and Hohenberger, Peter
, et al.
(2017)
In JAMA Oncology
3(5).
p.602-609
- Contribution to journal › Article
- 2014
-
Mark
Gastrointestinal Stromal Tumor: A Method for Optimizing the Timing of CT Scans in the Follow-up of Cancer Patients.
Joensuu, Heikki ; Reichardt, Peter ; Eriksson, Mikael LU
; Hall, Kirsten Sundby
and Vehtari, Aki
(2014)
In Radiology
271(1).
p.96-103
- Contribution to journal › Article
- 2012
-
Mark
One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor : A Randomized Trial
Joensuu, Heikki ; Eriksson, Mikael LU
; Hall, Kirsten Sundby
; Hartmann, Joerg T.
; Pink, Daniel
; Schuette, Jochen
; Ramadori, Giuliano
; Hohenberger, Peter
; Duyster, Justus
and Al-Batran, Salah-Eddin
, et al.
(2012)
In JAMA: The Journal of the American Medical Association
307(12).
p.1265-1272
- Contribution to journal › Article